$ORGO
Organogenesis Holdings Inc.

2019 Q2 Form 10-Q Financial Statement

#000119312519217411 Filed on August 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2 2018 Q1
Revenue $64.95M $43.55M $35.53M
YoY Change 49.13% -19.45% -10.81%
Cost Of Revenue $19.45M $17.30M $14.52M
YoY Change 12.4% 12.29% 9.14%
Gross Profit $45.50M $26.25M $21.01M
YoY Change 73.33% -32.1% -20.82%
Gross Profit Margin 70.06% 60.28% 59.13%
Selling, General & Admin $48.96M $37.74M $38.17M
YoY Change 29.74% 11.92% 36.54%
% of Gross Profit 107.59% 143.74% 181.67%
Research & Development $3.864M $2.048M $2.824M
YoY Change 88.67% -16.54% 82.08%
% of Gross Profit 8.49% 7.8% 13.44%
Depreciation & Amortization $859.0K $875.0K $872.0K
YoY Change -1.83%
% of Gross Profit 1.89% 3.33% 4.15%
Operating Expenses $52.82M $43.28M $40.99M
YoY Change 22.05% 19.65% 38.93%
Operating Profit -$7.319M -$17.03M -$19.98M
YoY Change -57.01% -782.36% 572.53%
Interest Expense $2.187M $2.781M $2.429M
YoY Change -21.36% 36.93% 52.58%
% of Operating Profit
Other Income/Expense, Net -$2.307M -$2.958M -$2.479M
YoY Change -22.01% 12.9% 72.51%
Pretax Income -$9.626M -$19.98M -$22.46M
YoY Change -51.83% 15886.4% 409.53%
Income Tax $23.00K $27.00K $28.00K
% Of Pretax Income
Net Earnings -$9.649M -$20.01M -$22.49M
YoY Change -51.78% -64648.39% -1088.48%
Net Earnings / Revenue -14.86% -45.95% -63.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$106.0K $40.82K -$10.31K
COMMON SHARES
Basic Shares Outstanding 91.32M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2018 Q2 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.00M $100.0K $100.0K
YoY Change 19900.0% -66.67% -80.0%
Cash & Equivalents $20.16M $1.310M $918.0K
Short-Term Investments
Other Short-Term Assets $3.200M $100.0K $200.0K
YoY Change 3100.0% -66.67% -50.0%
Inventory $18.72M
Prepaid Expenses
Receivables $34.16M
Other Receivables $0.00
Total Short-Term Assets $76.15M $200.0K $300.0K
YoY Change 37973.0% -66.67% -66.67%
LONG-TERM ASSETS
Property, Plant & Equipment $40.75M
YoY Change
Goodwill $25.54M
YoY Change
Intangibles $23.84M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.040M $314.8M $313.2M
YoY Change -99.67% 1.42% 1.03%
Total Long-Term Assets $91.93M $314.8M $313.5M
YoY Change -70.8% 1.22% 1.03%
TOTAL ASSETS
Total Short-Term Assets $76.15M $200.0K $300.0K
Total Long-Term Assets $91.93M $314.8M $313.5M
Total Assets $168.1M $315.0M $313.8M
YoY Change -46.64% 1.09% 0.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.28M
YoY Change
Accrued Expenses $20.68M $5.400M $4.800M
YoY Change 282.94% 5300.0% 4700.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $500.0K $300.0K
YoY Change -100.0%
Long-Term Debt Due $2.400M
YoY Change
Total Short-Term Liabilities $50.40M $5.900M $5.100M
YoY Change 754.22% 5800.0% 5000.0%
LONG-TERM LIABILITIES
Long-Term Debt $39.66M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.220M $10.90M $10.90M
YoY Change -42.94% 0.0% 0.0%
Total Long-Term Liabilities $45.88M $10.90M $10.90M
YoY Change 320.94% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.40M $5.900M $5.100M
Total Long-Term Liabilities $45.88M $10.90M $10.90M
Total Liabilities $144.9M $16.70M $15.90M
YoY Change 767.52% 53.21% 44.55%
SHAREHOLDERS EQUITY
Retained Earnings -$155.2M
YoY Change
Common Stock $178.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $728.5K
Shareholders Equity $23.20M -$57.17M -$37.44M
YoY Change
Total Liabilities & Shareholders Equity $168.1M $315.0M $313.8M
YoY Change -46.64% 1.09% 0.84%

Cashflow Statement

Concept 2019 Q2 2018 Q2 2018 Q1
OPERATING ACTIVITIES
Net Income -$9.649M -$20.01M -$22.49M
YoY Change -51.78% -64648.39% -1088.48%
Depreciation, Depletion And Amortization $859.0K $875.0K $872.0K
YoY Change -1.83%
Cash From Operating Activities -$12.11M -$210.0K -$4.457M
YoY Change 5666.67% -216.67% 3328.46%
INVESTING ACTIVITIES
Capital Expenditures -$1.180M $65.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.180M -$65.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.800M 180.0K 3.082M
YoY Change 1455.56% -816.74%
NET CHANGE
Cash From Operating Activities -12.11M -210.0K -4.457M
Cash From Investing Activities -1.180M -65.00K
Cash From Financing Activities 2.800M 180.0K 3.082M
Net Change In Cash -10.49M -30.00K -1.440M
YoY Change 34866.67% -85.0% 157.14%
FREE CASH FLOW
Cash From Operating Activities -$12.11M -$210.0K -$4.457M
Capital Expenditures -$1.180M $65.00K
Free Cash Flow -$10.93M -$4.522M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17025000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
90647352
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66361998
us-gaap Operating Income Loss
OperatingIncomeLoss
-19440000
us-gaap Operating Income Loss
OperatingIncomeLoss
-37006000
CY2019Q2 us-gaap Revenues
Revenues
64948000
CY2018Q2 us-gaap Revenues
Revenues
43552000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
19446000
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
17300000
CY2019Q2 us-gaap Gross Profit
GrossProfit
45502000
CY2018Q2 us-gaap Gross Profit
GrossProfit
26252000
CY2019Q2 us-gaap Cash
Cash
20040000
CY2018Q4 us-gaap Cash
Cash
21291000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
76146000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
71131000
CY2019Q2 us-gaap Assets
Assets
168074000
CY2018Q4 us-gaap Assets
Assets
163678000
CY2019Q2 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
20679000
CY2018Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
20388000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
50399000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
56096000
CY2019Q2 us-gaap Liabilities
Liabilities
144876000
CY2018Q4 us-gaap Liabilities
Liabilities
116637000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
178412000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177272000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-155223000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130240000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
23198000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
47041000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168074000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
163678000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7319000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48957000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37735000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3864000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2048000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
90625850
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65347076
us-gaap Revenues
Revenues
122071000
us-gaap Revenues
Revenues
79081000
us-gaap Cost Of Revenue
CostOfRevenue
36426000
us-gaap Cost Of Revenue
CostOfRevenue
31821000
us-gaap Gross Profit
GrossProfit
85645000
us-gaap Gross Profit
GrossProfit
47260000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97850000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75900000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7235000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
52821000
CY2019Q2 us-gaap Interest Expense
InterestExpense
2187000
CY2018Q2 us-gaap Interest Expense
InterestExpense
2781000
CY2018Q2 orgo Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
175000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
43277000
CY2019Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
33484000
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
26484000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40751000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39623000
CY2019Q2 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
516000
CY2018Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
477000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4711000
CY2019Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1632000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1759000
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9706000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6851000
CY2019Q2 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
265000
CY2018Q2 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
579000
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1157000
CY2019Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2307000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2958000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9626000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19983000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-9649000
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-20010000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4872000
us-gaap Operating Expenses
OperatingExpenses
105085000
us-gaap Operating Expenses
OperatingExpenses
84266000
us-gaap Interest Expense
InterestExpense
3965000
us-gaap Interest Expense
InterestExpense
5191000
orgo Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
249000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1862000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5815000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5437000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25255000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42443000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2019Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
119000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
114000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34157000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34077000
CY2019Q2 us-gaap Inventory Net
InventoryNet
18717000
CY2018Q4 us-gaap Inventory Net
InventoryNet
13321000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3113000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2328000
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23844000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26091000
CY2019Q2 us-gaap Goodwill
Goodwill
25539000
CY2018Q4 us-gaap Goodwill
Goodwill
25539000
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
238000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
238000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1040000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
579000
CY2018Q4 orgo Redeemable Common Stock Liability
RedeemableCommonStockLiability
6762000
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2545000
CY2019Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2442000
CY2018Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2236000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
22278000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19165000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79892000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79097000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
40206000
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
34359000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
344000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
297000
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1610000
CY2019Q2 us-gaap Secured Debt
SecuredDebt
635000
CY2019Q2 orgo Number Of Shares Issues As Collateral For Secured Debt
NumberOfSharesIssuesAsCollateralForSecuredDebt
675990
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2284000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5343000
CY2019Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
456000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
130000
CY2019Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14655000
CY2018Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
15418000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6220000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5931000
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
9000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5000000
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5000000
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
12578000
CY2019Q2 orgo Working Capital
WorkingCapital
25747000
CY2019Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
37178000
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
37497000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3021000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3420000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3292000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2957000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3420000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3225000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7266185
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.92
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11150
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.87
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7328352
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.99
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.55
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y10M20D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y6M3D
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4821000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2216000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
23968000
CY2018Q2 orgo Accrued Legal Expenses
AccruedLegalExpenses
1000000
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39662000
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
728548
CY2019Q2 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-374000
CY2019Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
103000
CY2018Q2 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-4000
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2853000
CY2018Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-100000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-426000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3021000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-65000
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7379000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1206000
CY2019Q2 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5776000
CY2018Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5265000
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
2154000
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
4308000
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
4308000
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
4738000
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Net Minimum Payments1
CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1
25064000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64185000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62435000
CY2019Q2 us-gaap Depreciation
Depreciation
859000
CY2018Q2 us-gaap Depreciation
Depreciation
875000
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1499000
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
917000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20679000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20388000
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15207000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15218000
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5472000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5170000
CY2019Q2 us-gaap Line Of Credit
LineOfCredit
33484000
CY2018Q4 us-gaap Line Of Credit
LineOfCredit
26484000
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
40000000
CY2018Q4 us-gaap Notes Payable
NotesPayable
15885000
CY2018Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
762000
CY2019Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
338000
CY2019Q1 orgo Additional Payment In Aggregate Of The Principal Amount Percentage
AdditionalPaymentInAggregateOfThePrincipalAmountPercentage
0.0625
CY2019Q1 orgo Percentage Available For Revolving Commitments
PercentageAvailableForRevolvingCommitments
0.25
CY2019Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
12222000
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
13333000
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
13333000
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1112000
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2018Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
5000000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5683274
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7050203
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25006426
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9496779
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
7967000
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
17097000
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
9556000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1180000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Four And Five Years
OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears
8124000
CY2019Q2 orgo Business Combination Contingent Consideration Liability Accrued Interest
BusinessCombinationContingentConsiderationLiabilityAccruedInterest
767000
CY2019Q2 orgo Accrued Interest Notes Receivable
AccruedInterestNotesReceivable
20000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92071270
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91261413
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91342722
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91261413
CY2018Q2 orgo Accrued Interest Notes Receivable
AccruedInterestNotesReceivable
20000
orgo Accrued Interest Notes Receivable
AccruedInterestNotesReceivable
39000
CY2019Q2 orgo Write Off Of Deferred Offering Costs
WriteOffOfDeferredOfferingCosts
0
CY2018Q2 orgo Write Off Of Deferred Offering Costs
WriteOffOfDeferredOfferingCosts
3494000
orgo Write Off Of Deferred Offering Costs
WriteOffOfDeferredOfferingCosts
0
orgo Write Off Of Deferred Offering Costs
WriteOffOfDeferredOfferingCosts
3494000
CY2019Q2 orgo Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
0
orgo Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
0
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21405000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2358000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20159000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1310000
us-gaap Interest Paid
InterestPaid
3890000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
32559000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-54000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-234000
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
263000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2019Q2 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
43850000
CY2019Q2 orgo Capital Lease Amount Of Minimum Rental Payments Increase In Each Year In Ten Year Option To Extend
CapitalLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInTenYearOptionToExtend
44000
CY2019Q2 orgo Capital Lease Amount Of Minimum Rental Payments Increase In Each Year In Five Year Option To Extend
CapitalLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInFiveYearOptionToExtend
33000
CY2019Q2 us-gaap Security Deposit
SecurityDeposit
526000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-15317000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-44000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-317000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-22488000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-37444000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-34000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-251000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-57169000
CY2019Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
332000
CY2019Q1 orgo Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
-628000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-224000
CY2019Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
0
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-15666000
CY2019Q2 us-gaap Other Liabilities
OtherLiabilities
780000
CY2018Q4 us-gaap Other Liabilities
OtherLiabilities
854000
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1603000
CY2018Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1104000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2925000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2153000
orgo Accrued Interest Notes Receivable
AccruedInterestNotesReceivable
39000
us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
21000
CY2019Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
62000
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
60000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
124000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
120000
CY2019Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
33339432
us-gaap Interest Paid
InterestPaid
2507000
us-gaap Income Taxes Paid
IncomeTaxesPaid
67000
us-gaap Income Taxes Paid
IncomeTaxesPaid
62000
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
33431891
us-gaap Profit Loss
ProfitLoss
-25315000
us-gaap Profit Loss
ProfitLoss
-42498000
us-gaap Depreciation
Depreciation
1761000
us-gaap Depreciation
Depreciation
1747000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2997000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1834000
orgo Non Cash Interest Expense
NonCashInterestExpense
154000
orgo Non Cash Interest Expense
NonCashInterestExpense
345000
orgo Non Cash Interest Income
NonCashInterestIncome
-536000
orgo Non Cash Interest Income
NonCashInterestIncome
-111000
orgo Non Cash Rent Expense Income
NonCashRentExpenseIncome
326000
orgo Non Cash Rent Expense Income
NonCashRentExpenseIncome
28000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-307000
orgo Provision For Inventory Reserve
ProvisionForInventoryReserve
523000
orgo Provision For Inventory Reserve
ProvisionForInventoryReserve
1833000
us-gaap Share Based Compensation
ShareBasedCompensation
458000
us-gaap Share Based Compensation
ShareBasedCompensation
568000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
249000
orgo Fair Value Adjustment Of Forfeiture Rights
FairValueAdjustmentOfForfeitureRights
589000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-723000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5342000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6087000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1648000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
785000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1857000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1473000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7217000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
122000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
524000
orgo Increase Decrease In Accrued Interest Of Affiliate Debt
IncreaseDecreaseInAccruedInterestOfAffiliateDebt
-1777000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-449000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
414000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21674000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20238000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1251000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
557000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
250000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1501000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-557000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
7000000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4827000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
40000000
orgo Proceeds From Affiliates Long Term Debt
ProceedsFromAffiliatesLongTermDebt
10000000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
17585000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
54000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
78000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
628000
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
6762000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
557000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
849000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
131000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21929000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19747000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1246000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1048000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
75000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
25000
orgo Non Cash Purchase Of Property Plant And Equipment
NonCashPurchaseOfPropertyPlantAndEquipment
1638000
orgo Non Cash Purchase Of Property Plant And Equipment
NonCashPurchaseOfPropertyPlantAndEquipment
529000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
500000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin: 18pt 0px 0pt 4%; line-height: 12pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-right: 0px;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported results of operations during the reporting period. Actual results could differ from those estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin: 18pt 0px 0pt 4%; line-height: 12pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Reclassification of Prior Period Balances </div></div></div></div><div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-right: 0px;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Reclassifications have been made to prior period amounts to conform to the current-year presentation of the reporting of deferred interest and principal on outstanding capital lease obligations and deferred tenant escalations as long-term liabilities on the consolidated balance sheets. The deferred interest and tenant escalation amounts were previously reported as accrued expenses on the consolidated balance sheets and the deferred principal on the capital lease obligations were recorded as part of the current portion of capital lease obligations on the consolidated balance sheet. These reclassifications have no effect on the reported net loss, equity or cash flow for the periods ended June&#160;30, </div>2018 or December&#160;31, 2018.<div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
7.08
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
5.40
CY2019Q2 orgo Fair Value Of Common Share
FairValueOfCommonShare
7.08
CY2018Q2 orgo Fair Value Of Common Share
FairValueOfCommonShare
5.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.08
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
26683
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.98
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Trading Symbol
TradingSymbol
ORGO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y4M20D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41129000
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
91343389
dei Security12b Title
Security12bTitle
Class A Common Stock
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
523000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
1833000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33909000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M25D
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37330000
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13486000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23844000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
36580000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10489000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26091000
CY2019Q1 us-gaap Line Of Credit Facility Covenant Terms
LineOfCreditFacilityCovenantTerms
Borrower&#8217;s achievement of trailing twelve month Consolidated Revenue of not less than $221,250 and a trailing three month Adjusted EBITDA (as defined in the New Credit Agreement) loss not in excess of $5,000;
CY2019Q1 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
interest rate equal to 3.75% above the Wall Street Journal Prime Rate
CY2018 us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
maintain Minimum Liquidity (as defined in the New Credit Agreement) equal to the greater of (i) 6 months Monthly Burn (as defined in the New Credit Agreement) and (ii) $10,000.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
78111
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0224
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0274
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M25D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.427
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.429
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
Organogenesis Holdings Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001661181
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019Q1 us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
728548
CY2019Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2018Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
3516000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
17000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
234000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
251000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
458000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
568000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
137000

Files In Submission

Name View Source Status
0001193125-19-217411-index-headers.html Edgar Link pending
0001193125-19-217411-index.html Edgar Link pending
0001193125-19-217411.txt Edgar Link pending
0001193125-19-217411-xbrl.zip Edgar Link pending
d769352d10q.htm Edgar Link pending
d769352dex311.htm Edgar Link pending
d769352dex312.htm Edgar Link pending
d769352dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
orgo-20190630.xml Edgar Link completed
orgo-20190630.xsd Edgar Link pending
orgo-20190630_cal.xml Edgar Link unprocessable
orgo-20190630_def.xml Edgar Link unprocessable
orgo-20190630_lab.xml Edgar Link unprocessable
orgo-20190630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending